The main provisions of the guidelines of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia on the population-based colorectal cancer screening

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths both globally and in Russia. Screening is a key element in the prevention and early diagnosis of CRC. This guide presents current guidelines aimed at managing effective CRC screening among the adult population as part of routine health examinations.

The primary goal of screening is to identify precancerous conditions and early stages of CRC for timely treatment and an improved prognosis. The guidelines include a list of target groups, particularly individuals aged 40 to 75 years, as well as individuals with a family history or other risk factors.

The key screening method is a immunochemical fecal occult blood test, followed by a colonoscopy in positive results. Particular attention is paid to compliance with standards for the preparation and conduct of examinations.

The guidelines outline the stages of patient care, from initial identification to specialized treatment, including regulatory frameworks and the use of information systems for monitoring and reporting outcomes.

These guidelines are rested on evidence-based medicine and are an essential tool for primary care specialists and healthcare executives.

1. Kaprin AD, Starinsky VV, Shakhzadova AO. Malignant neoplasms in Russia in 2022 (morbidity and mortality). Moscow: P.A. Herzen MNIOI — branch of FGBU "NMC Radiology" of the Ministry of Health of Russia; 2024. (In Russ.)

2. Primm KM, Malabay AJ, Curry T, et al. Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage. Cancer Med. 2023;12(13):14767- 80. doi:10.1002/cam4.6105.

3. Alinia S, Ahmadi S, Mohammadi Z, et al. F, Asghari-Jafarabadi M, Mahmoudi L, et al. Exploring the impact of stage and tumor site on colorectal cancer survival: Bayesian survival modeling. Sci Rep. 2024;14(1):4270. doi:10.1038/s41598-024-54943-8.

4. Afanasenkova TE, Samorodskaya IV, Oynotkinova OSh, et al. Regional trends in gastrointestinal tract cancer mortality in Russia for 2019-2021. Russian Journal of Evidence-Based Gastroenterology. 2023;12(2):15 24. (In Russ.) doi:10.17116/dokgastro20231202115.

5. Hoffmeister M. Interim evaluation of the colorectal cancer screening programme in the Netherlands. Lancet Gastroenterol Hepatol. 2022;7(1):8-9. doi:10.1016/S2468-1253(21)00392-7.

6. Tanaka K, Sobue T, Zha L et al. Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study. J Epidemiol. 2023;33(2):JE20210057. doi:10.2188/jea.JE20210057.

7. Gini A, Jansen EEL, Zielonke N et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review. Eur J Cancer. 2020;127:224- 35. doi:10.1016/j.ejca.2019.12.014.

8. Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ et al. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening. Int J Cancer. 2020;147(4): 1098-106. doi:10.1002/ijc.32839.

9. Recommendations on screening for colorectal cancer in primary care. Can Med Assoc J. 2016;188(5):340-8. doi:10.1503/cmaj.151125.

10. Qaseem A, Crandall CJ, Mustafa RA et al. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. Ann Intern Med. 2019;171(9):643-54. doi:10.7326/M19-0642.

11. Smith RA, Andrews KS, Brooks D et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210. doi:10.3322/caac.21557.

12. Davidson KW, Barry MJ, Mangione CM et al. Screening for Colorectal Cancer. JAMA. 2021;325(19):1965. doi:10.1001/jama.2021.6557.

13. Ukharsky AV, Nesterov PW, Kislov NV. Colorectal cancer screening program in Yaroslavl region: assessment of indirect costs. Medical Almanac. 2022;2(71):72- 84. (In Russ.)

14. Nikonov EL, Galkova ZV, Kashin SV, et al. Preparation for Introduction of a National Screening Program for Colorectal Cancer. Doctor.Ru. 2019;10(165):23- 30. (in Russ) doi:10.31550/1727-2378-2019-165-10-23-30.

15. Nikonov EL, Kuvaev RO, Zharova ME, et al. Early detection of gastrointestinal cancer: opportunities for the development of endoscopic services in the Russian Federation. Russian Journal of Evidence-Based Gastroenterology. 2024;13(4):69 80. (In Russ.) doi:10.17116/dokgastro20241304169.

16. Drozdova LYu, Ivanova ES, Egorov VA, et al. Routing of the adult population during preventive examination and medical check-up for the oncology pathology diagnosing. The Russian Journal of Preventive Medicine. 2023;26(12):7-11. (In Russ.). doi:10.17116/profmed2023261217

17. Nikonov EL, Aksenov VA, Kashin SV, et al. The international colorectal cancer screening programs. Russian Journal of Evidence-Based Gastroenterology. 2017;6(3):30 5. (In Russ.) doi:10.17116/dokgastro20176330-35

18. Severskaya NV, Nevolskikh AA, Avdeenko VA, et al. Fecal occult blood testing in colorectal cancer screening programs. Research and Practical Medicine Journal. 2022;9(3):145-59. (In Russ.) doi:10.17709/2410-1893-2022-9-3-11.

19. Moss S, Mathews C, Day TJ et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England. Gut. 2017;66(9):1631-44. doi:10.1136/gutjnl-2015-310691.

20. Shapiro JA, Bobo JK, Church TR, et al. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol. 2017;112(11):1728-35. doi:10.1038/ajg.2017.285.

21. Imperiale TF, Gruber RN, Stump TE, et al. Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps. Ann Intern Med. 2019;170(5):319. doi:10.7326/M18-2390.

22. Robertson DJ, Lee JK, Boland CR, et al. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US MultiSociety Task Force on Colorectal Cancer. Gastroenterology. 2017;152(5):1217-37. doi:10.1053/j.gastro.2016.08.053.

23. Meklin J, Eskelinen M, Guimaraes DP, et al. The Automatically Analyzed (AA) ColonView (CV) Quick Test for Fecal Occult Blood Shows Higher Diagnostic Accuracy in Detection of Colorectal Adenoma than Visually Analyzed Tests. Anticancer Res. 2021;41(11):5517-25. doi:10.21873/anticanres.15365.

24. Gies A, Cuk K, Schrotz-King P, et al. Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening. Gastroenterology. 2018;154(1):93-104. doi:10.1053/j.gastro.2017.09.018.

25. Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: A global overview of existing programmes. Gut. 2015;64(10):1637-49. doi:10.1136/gutjnl-2014-309086.

26. Sarkeala T, Färkkilä M, Anttila A, et al. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland. BMJ Open. 2021;11(2):e046667. doi:10.1136/bmjopen-2020-046667.

27. Blom J, Löwbeer C, Elfström KM et al. Gender-specific cut-offs in colorectal cancer screening with FIT: Increased compliance and equal positivity rate. J Med Screen. 2019;26(2):92-7. doi:10.1177/0969141318804843.

28. Ribbing Wilén H, Saraste D, Blom J. Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs. J Med Screen. 2021;28(4):439-47. doi:10.1177/09691413211020035.

29. Toes-Zoutendijk E, van Leerdam ME, Dekker E et al. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. Gastroenterology. 2017;152(4): 767-75. doi:10.1053/j.gastro.2016.11.022.

30. Nikonov ЕL. Faecal Tests in Colorectal Cancer Screening Programs. Doctor.Ru. 2018; 3(147):16-22. (In Russ.)

31. Andreev DA, Kashurnikov AYu, Zavyalov AA. Colorectal cancer screening: foreign guidelines on fecal immunochemical test cut-off (review). Voprosy Onkologii. 2021; 67(4):456-62. (In Russ.) doi:10.37469/0507-3758-2021-67-4-456-462

32. Ivashkin VT, Mayev IV, Kaprin AD, et al. Early Detection of Oncological Diseases of the Digestive System (Guidelines of the Russian Gastroenterological Association and the Russian Association of Oncologists for Primary Care Physicians). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(5):53-74. (In Russ.) doi:10.22416/1382-4376-2019-29-5-53-74.

33. Kashin SV, Nikonov EL, Nekhaykova NV, et al. Standards of quality colonoscopy (Guidelines for doctors). Russian Journal of Evidence-Based Gastroenterology. 2019; 8(1 2):3 32. (In Russ.) doi:10.17116/dokgastro20198012003.

34. Galkova ZV, Logunova PV, Zharova ME, et al. Informed consent in endoscopy. Examples of protocols. Russian Journal of Evidence-Based Gastroenterology. 2023;12(3):103 16. (In Russ.) doi:10.17116/dokgastro202312031103.

35. Kashin SV, Zavyalov DV, Malikhova OA, Abdrakhmanov RR. Guidelines for the management of patients with epithelial neoplasms of the colon: the executive summary for benign neoplasms. Russian Journal of Preventive Medicine. 2023;26(3):109 14. (In Russ.) doi:10.17116/profmed202326031109.

36. Zhuravleva MV, Serebrova SYu, Ponomarenko TM, et al. Clinical pharmacology of drugs for bowel cleansing prior to any diagnostic and/or surgical procedures requiring clean bowel: analysis of efficacy and safety parameters. Russian Journal of Evidence-Based Gastroenterology. 2020;9(1):50 67. (In Russ.) doi:10.17116/dokgastro2020901150.

37. Lai EJ, Calderwood AH, Doros G et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69(3):620-5. doi:10.1016/j.gie.2008.05.057.

38. Beluavskaja SV, Jukovskaja SE. The Assessment of the Bowel Preparation and Tolerability of Colonoscopy When Using a Combination of Drags Alverine Citrate with Simethicone and Polyethylenglycol.Recept. 2022;(5):652-9. (In Russ.) doi:10.34883/PI.2022.25.5.003.

39. Kashin SV, Zavyalov DV, Sidneva AV. The effect of alverine citrate plus simethicone (Meteospazmyl) on effectiveness and tolerability of bowel preparation for colonoscopy. Russian Journal of Evidence-Based Gastroenterology. 2023;12(2):34 44. (In Russ.) doi:10.17116/dokgastro20231202134.

40. Starkov YuG, Korolev MP, Starodubov VI, et al. Guidelines for equipment and support for endoscopic examinations (part one). Filin’s Clinical endoscopy. 2023;63(2):6-22. (In Russ.) doi:10.31146/2415-7813-endo-63-2-6-22.

41. Kashin SV, Zavyalov DV. Principles of photodocumentation in colonoscopy. Russian Journal of Evidence-Based Gastroenterology. 2024;13(1):86 93. (In Russ.) doi:10.17116/dokgastro20241301186.

42. Kashin SV, Zavyalov DV, Malikhova OA, et al. Guidelines for the management of patients with epithelial neoplasms of the colon: the executive summary for benign neoplasms. Russian Journal of Preventive Medicine. 2023;26(3):109 14. (In Russ.) doi:10.17116/profmed202326031109.